Citizens Financial Group’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,040
Closed -$109K 706
2025
Q1
$109K Buy
+27,040
New +$124K ﹤0.01% 607

Other funds holding PRPH

Citizens Financial Group's PRPH Position: Q2 2025 in Review

Citizens Financial Group sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 27,040 shares — an estimated $109K sold.

Citizens Financial Group first reported a position in PRPH in Q1 2025 and held it in 1 quarter. The position peaked at $109K in Q1 2025. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Citizens Financial Group reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Citizens Financial Group sold 27,040 ProPhase Labs shares in Q2 2025, an estimated $109K.
  • Citizens Financial Group first reported a position in ProPhase Labs in Q1 2025 and held it in 1 quarter.
  • Citizens Financial Group's ProPhase Labs position peaked at $109K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Citizens Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.